GLOBAL IMMUNE TECHNOLOGIES INC. Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31)
GLOBAL IMMUNE TECHNOLOGIES INC. had Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) of $5.21 million as of 2013-09-30, per its 10-Q filed 2013-11-19.
Discontinued › Notes
us-gaap:DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage · last filed 2013-11-19
- 2013-09-30: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $5.21M.
- 2013-03-31: Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) $4.83M.
| Period end | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) |
|---|---|
| 2013-09-30 | $5.21M 10-Q · filed 2013-11-19 |
| 2013-03-31 | $4.83M 10-Q · filed 2013-11-19 |